EFPIA - NEWSLETTER

EFPIA Newsletter 20 May 2021

Five steps to urgently advance COVID-19 vaccine equity

Five steps to urgently advance COVID-19 vaccine equity 19 May 2021

Immediate action must focus on stepping up responsible dose sharing and maximizing production without compromising quality or safety. To do so, innovative vaccine manufacturers and biotech companies commit to:

1) Step up dose sharing
2) Continue to optimize production
3) Call out trade barriers to be eliminated
4) Support country readiness
5) Drive further innovation

The Impact of COVID-19 on Patient Access to Cancer Care in Europe

The pandemic has hit every aspect of cancer care, putting patients at higher risk of poor outcomes. A new report sets out 6 ways to regain lost momentum and build on positive lessons learned during the crisis.

The publication was commissioned to Vintura by the EFPIA Oncology Platform and developed with a wide range of stakeholders, including patient organisations, healthcare providers, payers, HTA bodies and academic institutions. Read more.

From our blog

20 May 2021 EFPIA members continue to be committed to responsible clinical trial data sharing

Our commitment to patients and researchers

20 May 2021 The hidden pandemic: the melanoma patient experience during the COVID-19 pandemic (Guest...

Melanoma is the most severe and life-threatening form of skin cancer

19 May 2021 How can machine learning serve patients and enable value-based healthcare? (Guest blog)

Machine learning to identify and characterise metastatic breast cancer patients in Sweden: a population-based study

12 May 2021 A tribute to Nurses and to my Mother

You are truly unsung heroes who keep our healthcare systems running and most of all, who give us the care, love and...

Events

25 MAY 2021

Unlocking the potential of the European Health Data Space to improve diabetes management... Virtual event

The first in a two-part series co-hosted by the EFPIA Diabetes Platform and the European Diabetes Forum (EUDF)

Learn more →

17 JUN 2021

Lessons from the crisis: how a value-based approach can make health systems more... Virtual event

An event by the European Alliance for Value in Health

Learn more →

Today is International Clinical Trials Day!

Clinical trials are essential in bringing life-changing new treatments & vaccines to patients. Today we celebrate those volunteers, patients, scientists, researchers and regulators that contribute to around 60,000 ongoing clinical trials in Europe!

Today is also an opportunity to thank the thousands of volunteers that have participated in trials to protect citizens around the world with safe and effective COVID-19 vaccines and treatments. Without you this wouldn't be possible! You can read more about clinical trials on our webpage.

What we are reading

Big Pharma Commits to 5-Point Plan to Increase COVID-19 Vaccine Equity 19 May 2021 (Health Policy Watch)

How can more covid-19 vaccines be made available? 15 May 2021 (The Economist)

Medicines for children and rare diseases: Commission launches a public consultation 10 May 2021 (European Commission)

Transforming health and social care systems: the role of regions in fostering value-based healthcare... 03 May 2021 (European Alliance for Value in Health)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶